| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
56 |
| Equity
Latest Equity |
10.63 |
| Face Value
Latest Face Value |
1 |
| Reserves
Total Reserve |
1182.32 |
| Dividend
Full Year Dividend % |
50 |
| Sales Turnover
Full Year Net Sales |
927.11 |
| Net Profit
Full Year Net Profit |
131.92 |
| Full Year CPS
Full Year Cash Per Share |
15.6 |
| Earning Per Share
Full Year Earning Per Share |
12.4 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Jun 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
285.58 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
112.3 |
| Networth
Full Year Return on Networth |
12.01 |
| Price/Book Value
Price to Book value |
4.630454 |
| Yearly PE ratio
Full Year Price to Earning per share |
41.9 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
33.4 |
| Bse value
BSE Value in lakhs |
130.19 |
| Nse value
NSE Value in lakhs |
1827.72 |
| High
52 week high |
553 |
| Low
52 week low |
118 |
| Price
NSE Current market price |
521 |
| CPM
Current market price |
520 |
| Market cap
BSE / NSE Market Cap |
5521 |
| Net profit
Latest Quarter Net Profit |
50.1 |
| Net profit variance
Latest Quarter Net Profit variance |
16 |
| Result year
Trailing latest month |
Jun 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
800.17 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
121.14 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
15.14 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
237.18 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
23.59 |
| TTM NP
Trailing Twelve 12 month Net Profit |
84.18 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
29.12 |
| TTM EPS
Trailing Twelve 12 month EPS |
12.96 |
| TTM PE
Trailing Twelve 12 month PE |
40.08 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
27.63 |
| Equity
Latest Equity |
10.63 |
| LTP
Latest Price (BSE/NSE) |
520 |
| Gross block
Latest Gross Block |
608.12 |
| Loans
Total loans |
18.82 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
17.9 |
| Year GPM
Full Year Gross Profit Margin |
24.5 |
| Quarter OPM
Latest quater Operation Profit Margin |
26.8 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 218 | 210 | 198 | 207 | 244 | 218 | 257 | 286 |
| YOY Sales Growth % | 3% | 5% | -0% | 13% | 12% | 4% | 30% | 38% |
| Gross Sales | 218 | 210 | 198 | 207 | 244 | 218 | 257 | 286 |
| + Expenses | 176 | 181 | 177 | 166 | 201 | 186 | 213 | 209 |
| Material Cost % | 45% | 47% | 34% | 56% | 31% | 42% | 50% | 31% |
| Raw Material Cost | 100 | 97 | 77 | 93 | 95 | 86 | 111 | 95 |
| Change in Inventory | -3 | 2 | -9 | 22 | -20 | 5 | 16 | -5 |
| Manufacturing Cost % | 16% | 17% | 25% | 21% | 20% | 22% | 24% | 18% |
| Employee Cost % | 13% | 14% | 14% | 15% | 14% | 16% | 14% | 15% |
| Other Cost % | 8% | 7% | 16% | -11% | 18% | 5% | -5% | 9% |
| Raw Materials % | 46% | 46% | 39% | 45% | 39% | 40% | 43% | 33% |
| Purchase of Finished Goods % | 5% | 9% | 7% | 10% | 1% | 9% | 7% | 5% |
| Stock Adjustments % | 1% | -1% | 5% | -11% | 8% | -2% | -6% | 2% |
| Other Manufacturing Expenses % | 16% | 17% | 25% | 21% | 20% | 22% | 24% | 18% |
| Operating Profit | 41 | 30 | 21 | 41 | 43 | 32 | 44 | 76 |
| OPM % | 19% | 14% | 11% | 20% | 18% | 15% | 17% | 27% |
| + Other Income | 5 | 15 | 12 | 35 | 8 | 18 | 11 | 10 |
| Miscellaneous Income | 5 | 15 | 12 | 35 | 8 | 18 | 11 | 10 |
| Exceptional Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 4 | 1 | 2 | 5 | 3 | 1 | 2 | 1 |
| Depreciation | 7 | 8 | 8 | 8 | 8 | 8 | 9 | 10 |
| Profit before tax | 36 | 36 | 23 | 63 | 41 | 41 | 45 | 75 |
| + Tax % | 28% | 29% | 29% | 30% | 30% | 39% | 18% | 32% |
| Current Tax | 11 | 14 | 6 | 20 | 14 | 15 | 20 | 17 |
| Deferred Tax | -1 | -3 | 1 | -2 | -2 | 2 | -12 | 7 |
| + Net Profit | 26 | 26 | 17 | 44 | 29 | 25 | 37 | 51 |
| Extraordinary Income / Expense | 0 | 0 | 0 | 0 | 0 | -3 | 0 | 0 |
| Exceptional Item | 0 | 0 | 0 | 0 | 0 | -3 | 0 | 0 |
| Minority Interest (After Tax) | -1 | -2 | -1 | -1 | -1 | -2 | -1 | -1 |
| Net Profit After Minority Interest | 24 | 24 | 16 | 43 | 27 | 23 | 36 | 50 |
| EPS in Rs | 2.31 | 2.27 | 1.47 | 4.08 | 2.58 | 2.20 | 3.37 | 4.73 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Sales | 802 | 815 | 899 | 689 | 577 | 747 | 752 | 770 | 810 | 927 |
| Sales Growth % | 2% | 10% | -23% | -16% | 29% | 1% | 2% | 5% | 14% | |
| Gross Sales | 768 | 809 | 899 | 689 | 577 | 747 | 752 | 770 | 810 | 927 |
| Excise Duty | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Income | 26 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Expenses | 600 | 652 | 741 | 579 | 471 | 703 | 634 | 649 | 683 | 766 |
| Material Cost % | 45% | 48% | 68% | 64% | 57% | 52% | 53% | 50% | 51% | 46% |
| Raw Material Cost | 369 | 392 | 619 | 436 | 342 | 420 | 374 | 390 | 422 | 448 |
| Change in Inventory | -10 | -1 | -7 | 4 | -12 | -29 | 27 | -8 | -8 | -22 |
| Manufacturing Cost % | 2% | 3% | 1% | 2% | 3% | 3% | 3% | 4% | 3% | 4% |
| Employee Cost % | 8% | 8% | 5% | 8% | 12% | 10% | 11% | 12% | 14% | 15% |
| Other Cost % | 20% | 21% | 8% | 10% | 10% | 29% | 17% | 18% | 16% | 18% |
| Raw Materials % | 46% | 48% | 69% | 63% | 59% | 56% | 50% | 51% | 52% | 48% |
| Purchase of Finished Goods % | 3% | 1% | 45% | 25% | 14% | 5% | 6% | 7% | 6% | 7% |
| Stock Adjustments % | 1% | 0% | 1% | -1% | 2% | 4% | -4% | 1% | 1% | 2% |
| Power & Fuel % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 2% |
| Other Manufacturing Expenses % | 2% | 2% | 1% | 1% | 2% | 2% | 2% | 2% | 2% | 2% |
| Selling & Administration % | 15% | 11% | 6% | 7% | 8% | 11% | 11% | 11% | 12% | 13% |
| Miscellaneous Expenses % | 5% | 10% | 3% | 4% | 2% | 18% | 6% | 7% | 4% | 5% |
| Operating Profit | 203 | 163 | 158 | 110 | 107 | 45 | 117 | 121 | 127 | 162 |
| OPM % | 25% | 20% | 18% | 16% | 18% | 6% | 16% | 16% | 16% | 17% |
| + Other Income | 13 | 27 | 38 | 39 | 20 | 31 | 18 | 29 | 36 | 74 |
| Miscellaneous Income | 13 | 27 | 38 | 39 | 20 | 32 | 18 | 29 | 37 | 74 |
| Exceptional Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 20 | 23 | 4 | 8 | 6 | 5 | 10 | 7 | 8 | 12 |
| Depreciation | 20 | 21 | 9 | 13 | 17 | 17 | 19 | 26 | 29 | 33 |
| Profit before tax | 175 | 145 | 182 | 129 | 104 | 54 | 106 | 117 | 126 | 190 |
| + Tax % | 36% | 39% | 30% | 26% | 29% | 57% | 28% | 30% | 28% | 29% |
| Current Tax | 63 | 57 | 56 | 37 | 26 | 39 | 41 | 32 | 39 | 69 |
| Deferred Tax | 0 | -1 | -1 | -3 | 4 | -8 | -11 | 3 | -4 | -14 |
| + Net Profit | 113 | 89 | 127 | 95 | 74 | 23 | 77 | 82 | 90 | 135 |
| Profit Growth % | -21% | 43% | -25% | -22% | -69% | 232% | 6% | 11% | 49% | |
| Extraordinary Income / Expense | 0 | -34 | 0 | -13 | 0 | -74 | 0 | -29 | 0 | -2 |
| Exceptional Item | 0 | -34 | 0 | -13 | 0 | -74 | 0 | -29 | 0 | -2 |
| Minority Interest (After Tax) | -31 | -30 | -3 | 2 | -5 | -8 | -6 | -6 | -6 | -6 |
| Net Profit After Minority Interest | 82 | 59 | 124 | 97 | 68 | 15 | 71 | 75 | 84 | 129 |
| EPS in Rs | 10.92 | 8.60 | 12.28 | 9.23 | 7.17 | 2.23 | 7.37 | 7.79 | 8.57 | 12.74 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 |
| Reserves | 476 | 526 | 636 | 725 | 798 | 808 | 873 | 957 | 1,040 | 1,182 |
| + Borrowings | 225 | 118 | 102 | 126 | 122 | 109 | 102 | 100 | 88 | 22 |
| Secured Borrowings | 201 | 102 | 96 | 104 | 98 | 68 | 71 | 63 | 71 | 3 |
| Unsecured Borrowings | 24 | 16 | 6 | 23 | 24 | 41 | 31 | 37 | 17 | 19 |
| + Other Liabilities | 311 | 206 | 157 | 168 | 147 | 181 | 171 | 145 | 163 | 278 |
| Current Liabilities | 244 | 198 | 142 | 155 | 128 | 165 | 153 | 130 | 175 | 257 |
| Provisions | 51 | 11 | 14 | 20 | 11 | 12 | 3 | 2 | 4 | 35 |
| Minority Interest | 66 | 11 | 14 | 15 | 20 | 28 | 34 | 36 | 41 | 39 |
| Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other liability items | 2 | 2 | 2 | 3 | 3 | 1 | 3 | 3 | 4 | 12 |
| Total Liabilities | 1,023 | 860 | 905 | 1,030 | 1,077 | 1,109 | 1,157 | 1,212 | 1,301 | 1,492 |
| + Fixed Assets | 305 | 143 | 146 | 242 | 234 | 281 | 379 | 370 | 406 | 459 |
| Gross Block | 328 | 164 | 171 | 277 | 286 | 344 | 459 | 468 | 532 | 608 |
| Accumulated Depreciation | 23 | 21 | 25 | 35 | 51 | 63 | 81 | 98 | 126 | 149 |
| CWIP | 4 | 0 | 47 | 0 | 2 | 22 | 3 | 8 | 21 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 2 | 8 | 4 | 4 | 5 |
| + Other Assets | 714 | 717 | 712 | 788 | 840 | 803 | 768 | 830 | 871 | 1,022 |
| Inventories | 49 | 59 | 77 | 77 | 99 | 124 | 103 | 118 | 126 | 151 |
| Trade receivables | 254 | 298 | 461 | 548 | 464 | 393 | 385 | 404 | 439 | 517 |
| Cash Equivalents | 151 | 89 | 107 | 103 | 145 | 178 | 103 | 216 | 213 | 167 |
| Loans n Advances | 113 | 249 | 50 | 48 | 62 | 96 | 123 | 96 | 104 | 156 |
| Other asset items | 147 | 21 | 18 | 12 | 71 | 13 | 53 | -5 | -11 | 31 |
| Total Assets | 1,023 | 860 | 905 | 1,030 | 1,077 | 1,109 | 1,157 | 1,212 | 1,301 | 1,492 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Cash from Operating Activity | 289 | 18 | 40 | 47 | 64 | 135 | 34 | 103 | 106 | 139 |
| Profit from Operations | 212 | 197 | 171 | 156 | 150 | 96 | 164 | 184 | 196 | 285 |
| Working Capital Changes | 113 | -141 | -183 | -70 | -58 | 73 | -85 | -47 | -51 | -104 |
| Profit Before Tax & Extraordinary Items | 175 | 179 | 182 | 129 | 104 | 128 | 106 | 146 | 126 | 190 |
| Depreciation | 20 | 21 | 9 | 13 | 17 | 17 | 19 | 26 | 29 | 33 |
| Interest (Net) | 6 | 15 | -2 | 1 | -4 | -4 | 3 | -5 | -7 | -5 |
| Profit / Loss on Sale of Assets | 0 | -3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Profit / Loss on Sale of Investments | 0 | -8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Provisions & Write-offs (Net) | 6 | -2 | 10 | 26 | 7 | -47 | 30 | 36 | 36 | 29 |
| Profit / Loss in Forex | 4 | -6 | -30 | -12 | 17 | -4 | 3 | -23 | -6 | -23 |
| Receivables | 98 | -37 | -182 | -79 | 63 | 51 | -15 | -45 | -42 | -88 |
| Inventories | -11 | -9 | -18 | 1 | -27 | -29 | 15 | -22 | -30 | -46 |
| Trade Payables | 0 | -40 | 21 | 13 | -15 | 18 | -6 | -25 | 11 | 33 |
| Loans & Advances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Borrowing | 63 | -82 | -41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Direct Taxes Paid | -36 | -39 | 52 | -39 | -29 | -34 | -45 | -35 | -37 | -42 |
| + Cash from Investing Activity | -249 | 48 | -79 | -40 | -45 | -103 | -6 | -83 | -75 | -38 |
| Purchase of Fixed Assets | -104 | -28 | -44 | -59 | -9 | -74 | -94 | -28 | -76 | -57 |
| Sale of Fixed Assets | 0 | 4 | 6 | 1 | 0 | 1 | 1 | 1 | 3 | 3 |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | -2 | -8 | -1 | -36 | -59 |
| Sale of Investments | 0 | 3 | 0 | 0 | 0 | 0 | 2 | 5 | 37 | 59 |
| Interest Received | 6 | 11 | 4 | 8 | 5 | 6 | 13 | 5 | 16 | 17 |
| Acquisition of Companies | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others | -151 | 58 | -44 | 10 | -42 | -34 | 79 | -65 | -19 | -9 |
| + Cash from Financing Activity | -10 | -76 | 17 | -6 | -21 | -24 | -25 | -21 | -30 | -89 |
| Proceeds from Issue of Shares | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 3 | 2 |
| Proceeds from Other Long-Term Borrowings | 0 | 0 | 27 | 28 | 10 | 11 | 40 | 15 | 55 | 4 |
| Share Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Long-Term Borrowings | 0 | 0 | 0 | -15 | -16 | -26 | -54 | -24 | -72 | -64 |
| Repayment of Financial Liabilities | 0 | 0 | 0 | -2 | -2 | -2 | -1 | -3 | -4 | -5 |
| Dividend Paid | 0 | -7 | -8 | -13 | -6 | -5 | -5 | -5 | -5 | -11 |
| Interest Paid | -12 | -24 | -2 | -5 | -6 | -3 | -6 | -6 | -7 | -15 |
| Others | 2 | -45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 30 | -10 | -22 | 0 | -2 | 9 | 3 | -1 | 0 | 11 |